Abstract
Inflammation may have a pathogenic role in the progression of nonalcoholic fatty liver disease (NAFLD); by contrast, the role of anti-inflammatory molecules has not been addressed. Low circulating levels of the anti-inflammatory molecule IGF-I have been described in subjects with NAFLD.
Lingua originale | English |
---|---|
pagine (da-a) | E304-E308 |
Numero di pagine | 5 |
Rivista | THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM |
Volume | 98 |
Stato di pubblicazione | Published - 2013 |
All Science Journal Classification (ASJC) codes
- ???subjectarea.asjc.2700.2712???
- ???subjectarea.asjc.1300.1303???
- ???subjectarea.asjc.1300.1310???
- ???subjectarea.asjc.1300.1308???
- ???subjectarea.asjc.2700.2704???